LPCAT3 and carcinoma: Accumulating evidence suggests that pharmacological manipulation of LPCAT3 activity might provide novel therapeutic methods with respect to the pathological state of atherosclerosis, non‐alcoholic steatohepatitis, carcinoma, and immuno‐ and inflammatory disorders, etc. 16.